NEW YORK (GenomeWeb News) – Maternal and fetal health firm Carmenta Bioscience today said that it has raised more than $2 million in seed funding.

The Palo Alto, Calif.-based firm plans to use proceeds from the financing to continue development of its test for diagnosing preeclampsia in pregnant women and to commercialize the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.